| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.33 | 2e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.32 | 8e-11 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.077 | 0.2 |